Med Center Health Infectious Disease doctor named a Fellow by the Infectious Diseases Society of America
Dr. Patricia Tellez Watson, an Infectious Disease and Travel Medicine Specialist at The Medical Center at Bowling Green, has been named a Fellow by the Infectious Diseases Society of America (IDSA). Fellowship in IDSA is one of the highest honors in the field of infectious diseases. It recognizes distinguished physicians and scientists from the United States and around the world who have achieved professional excellence and provided significant service to the profession.
Dr. Tellez Watson is a graduate of Cayetano Heredia School of Medicine in Peru, completed her residency at Johns Hopkins/Sinai Hospital of Baltimore Internal Medicine Program, and fellowship at the University of Maryland Medical Center in Baltimore.
“I have had the privilege of working with Dr. Watson over the past several years and hold her in high esteem,” said Dr. William H. Moss, Chief Medical Officer of Med Center Health. “She is an indispensable part of our healthcare team, as her foresight and ingenuity have allowed us to decrease infectious issues and improve patient safety. Her passion for and care for her patients is inspirational. We are fortunate to have such a talented physician here at Med Center Health.”
Dr. Tellez Watson joined Med Center Health seven years ago, where she provides specialized care for infectious diseases (ID). Dr. Tellez Watson’s expertise is in general ID, mycobacterial infections, HIV, chronic viral hepatitis and STI care, Tropical and Travel medicine, and Antimicrobial Stewardship. She is also focused on the performance of antibiotic skin allergy testing, skin biopsies and bedside percutaneous needle bone biopsies to assist in the diagnostic work up and management of her patients. She serves as the director of the infectious disease department, as the Medical Executive Committee vice-president. She is also the Chair of the antibiotic stewardship program, and participates on the sepsis and the infection prevention and control committees.
“The 128 individuals chosen to receive the FIDSA designation this year have demonstrated a commitment to advancing ID, and we are proud to honor their work and dedication,” said Steven K. Schmitt, MD, FIDSA, president of IDSA. “These ID physicians and scientists represent a community of leaders around the globe who are on the front lines of research and clinical care and represent the passion and commitment to educate and protect us from dangerous illness. We all benefit from their vital contributions to our communities, and I am proud to work and learn alongside them.”
Applicants for IDSA Fellowship must be nominated by their peers and meet specified criteria that include continuing identification in the field of infectious diseases, national or regional recognition and publication of their scholarly work. Nominees are reviewed and elected by the IDSA Board of Directors. Fellows of IDSA work in many different settings, including clinical practice, teaching, research, public health and health care administration.